Literature DB >> 21432660

Current negative mood encourages changes in end-of-life treatment decisions and is associated with false memories.

Stefanie J Sharman1.   

Abstract

To investigate the effects of mood on people's end-of-life treatment decisions and their false memories of those decisions, participants took part in two sessions. At Time 1, participants were experimentally induced into positive or negative moods. They decided whether they would want to receive or refuse treatments in a range of hypothetical medical scenarios, such as tube feeding while in a coma. Four weeks later, at Time 2, participants were induced into the same or the opposite mood and made these decisions a second time. They also recalled their previous decisions. Participants in negative moods at Time 2 changed more of their current decisions and falsely remembered more of their previous decisions than participants in positive moods. These findings suggest that people's current moods influence whether they change their treatment decisions; current decisions in turn bias recall of past decisions.
© 2010 Psychology Press, an imprint of the Taylor & Francis Group, an Informa business

Entities:  

Mesh:

Year:  2011        PMID: 21432660     DOI: 10.1080/02699931003612064

Source DB:  PubMed          Journal:  Cogn Emot        ISSN: 0269-9931


  3 in total

1.  Use of the Physician Orders for Life-Sustaining Treatment program for patients being discharged from the hospital to the nursing facility.

Authors:  Susan E Hickman; Christine A Nelson; Esther Smith-Howell; Bernard J Hammes
Journal:  J Palliat Med       Date:  2013-12-18       Impact factor: 2.947

Review 2.  Stability of end-of-life preferences: a systematic review of the evidence.

Authors:  Catherine L Auriemma; Christina A Nguyen; Rachel Bronheim; Saida Kent; Shrivatsa Nadiger; Dustin Pardo; Scott D Halpern
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

3.  Instability in End-of-Life Care Preference Among Heart Failure Patients: Secondary Analysis of a Randomized Controlled Trial in Singapore.

Authors:  Chetna Malhotra; Meibo Hu; Rahul Malhotra; David Sim; Fazlur Rehman Jaufeerally; Filipinas G Bundoc; Eric A Finkelstein
Journal:  J Gen Intern Med       Date:  2020-02-26       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.